Guggenheim Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.03M Buy
36,868
+2,588
+8% +$142K 0.02% 656
2025
Q1
$2.42M Sell
34,280
-3,400
-9% -$240K 0.02% 586
2024
Q4
$2.48M Sell
37,680
-2,275
-6% -$150K 0.02% 580
2024
Q3
$2.81M Sell
39,955
-1,367
-3% -$96.1K 0.02% 708
2024
Q2
$3.4M Sell
41,322
-4,730
-10% -$389K 0.02% 644
2024
Q1
$4.02M Buy
46,052
+4,487
+11% +$392K 0.03% 634
2023
Q4
$4.01M Sell
41,565
-3,690
-8% -$356K 0.03% 592
2023
Q3
$4M Sell
45,255
-4,350
-9% -$385K 0.03% 560
2023
Q2
$4.3M Buy
49,605
+6,704
+16% +$581K 0.03% 572
2023
Q1
$4.17M Sell
42,901
-5,004
-10% -$487K 0.04% 583
2022
Q4
$4.96M Buy
47,905
+2,024
+4% +$209K 0.04% 530
2022
Q3
$3.89M Sell
45,881
-10,087
-18% -$855K 0.04% 590
2022
Q2
$4.64M Sell
55,968
-2,878
-5% -$238K 0.04% 572
2022
Q1
$4.54M Sell
58,846
-7,161
-11% -$552K 0.03% 686
2021
Q4
$5.83M Buy
66,007
+2,148
+3% +$190K 0.03% 622
2021
Q3
$4.94M Buy
63,859
+997
+2% +$77.1K 0.03% 660
2021
Q2
$5.25M Sell
62,862
-2,131
-3% -$178K 0.03% 658
2021
Q1
$4.91M Buy
64,993
+3,216
+5% +$243K 0.03% 635
2020
Q4
$5.42M Sell
61,777
-46,553
-43% -$4.08M 0.03% 543
2020
Q3
$8.24M Sell
108,330
-4,605
-4% -$350K 0.06% 341
2020
Q2
$13.9M Buy
112,935
+8,418
+8% +$1.04M 0.11% 177
2020
Q1
$8.83M Sell
104,517
-19,436
-16% -$1.64M 0.09% 239
2019
Q4
$10.5M Buy
123,953
+10,079
+9% +$852K 0.08% 305
2019
Q3
$7.68M Sell
113,874
-2,196
-2% -$148K 0.06% 405
2019
Q2
$9.94M Sell
116,070
-6,266
-5% -$537K 0.08% 292
2019
Q1
$10.9M Buy
122,336
+5,570
+5% +$495K 0.09% 258
2018
Q4
$9.94M Sell
116,766
-6,341
-5% -$540K 0.08% 261
2018
Q3
$11.9M Sell
123,107
-5,632
-4% -$546K 0.08% 296
2018
Q2
$12.1M Sell
128,739
-3,663
-3% -$345K 0.08% 270
2018
Q1
$10.7M Buy
132,402
+1,944
+1% +$158K 0.03% 656
2017
Q4
$11.6M Sell
130,458
-17,699
-12% -$1.58M 0.03% 642
2017
Q3
$13.8M Buy
148,157
+5,201
+4% +$484K 0.03% 580
2017
Q2
$13M Buy
142,956
+3,163
+2% +$287K 0.03% 593
2017
Q1
$12.3M Buy
139,793
+900
+0.6% +$79K 0.03% 609
2016
Q4
$11.5M Sell
138,893
-7,848
-5% -$650K 0.03% 621
2016
Q3
$13.6M Sell
146,741
-3,726
-2% -$345K 0.04% 581
2016
Q2
$11.7M Buy
150,467
+455
+0.3% +$35.4K 0.04% 621
2016
Q1
$12.4M Sell
150,012
-40,356
-21% -$3.33M 0.04% 641
2015
Q4
$19.9M Sell
190,368
-22,865
-11% -$2.4M 0.06% 562
2015
Q3
$22.5M Buy
213,233
+7,598
+4% +$800K 0.07% 510
2015
Q2
$28.1M Buy
205,635
+19,747
+11% +$2.7M 0.07% 516
2015
Q1
$23.2M Buy
185,888
+22,502
+14% +$2.8M 0.05% 603
2014
Q4
$14.8M Buy
163,386
+9,941
+6% +$899K 0.04% 708
2014
Q3
$11.1M Buy
153,445
+900
+0.6% +$64.9K 0.03% 843
2014
Q2
$9.49M Sell
152,545
-20,826
-12% -$1.3M 0.02% 871
2014
Q1
$11.8M Buy
173,371
+17,577
+11% +$1.2M 0.03% 799
2013
Q4
$10.9M Sell
155,794
-3,778
-2% -$266K 0.03% 795
2013
Q3
$11.5M Sell
159,572
-30,022
-16% -$2.17M 0.04% 776
2013
Q2
$10.6M Buy
+189,594
New +$10.6M 0.04% 741